Iminosugars have attracted increasing attention as chemical probes, chaperones and leads for drug discovery. Despite several clinical successes, their de novo synthesis remains a significant challenge that also limits their integration with modern high-throughput screening technologies. Herein, we describe a unique synthetic strategy that converts a wide range of acetaldehyde derivatives into iminosugars and imino-C-nucleoside analogues in two or three straightforward transformations. We also show that this strategy can be readily applied to the rapid production of indolizidine and pyrrolizidine iminosugars. The high levels of enantio- and diastereoselectivity, excellent overall yields, convenience and broad substrate scope make this an appealing process for diversity-oriented synthesis, and should enable drug discovery efforts.
Iminosugars are naturally occurring carbohydrate mimics that inhibit many enzymes of medicinal interest1. Their biological activity is often attributed to a structural resemblance to the oxacarbenium ion-like transition states that occur during the enzymatic hydrolysis of carbohydrates2. As such, many iminosugars are potent inhibitors of glycosidases and glycosyltransferases1, and have been highlighted as lead candidates for the treatment of a variety of diseases, including cancer, diabetes, viral infections and lysosomal storage disorders (for example, Gaucher and Fabry disease)1,3. The most common naturally occurring iminosugars possess a polyhydroxylated pyrrolidine core and may be additionally annulated as in the pyrrolizidines (for example, 2, Fig. 1), indolizidines (for example, 3), or nortropanes4. A growing number of unnatural analogues of these compounds have also been reported as leads for drug discovery, including the imino-C-nucleosides developed by Schramm (for example, 1)5,6 and β-hexosaminidase inhibitors developed by Wong7,8. Unfortunately, the incorporation of pyrrolidine iminosugars into chemical screening libraries or diversity-oriented synthesis (DOS) campaigns is problematic, as their syntheses are often lengthy, low-yielding, cost-intensive and limited by reliance on carbohydrate building blocks9. Thus, while several such pyrrolidine iminosugars have emerged as clinical candidates or drugs1, fundamental tools for their high-throughput synthesis are lacking. In fact, much of the success in imino-C-nucleoside synthesis10,11,12,13,14 (for example, 1 (ref. 6) and 4 (ref. 5)) has relied on the common building block 5 (refs 14, 15, 16). As evidenced by step counts provided in Fig. 1, the synthesis of pyrrolizidine- and indolizidine-based iminosugars (for example, 2; (ref. 17) and 3; (ref 18)) also remains a significant synthetic challenge.
We have reported preliminarily that when mixtures of the dioxanone 8, an aliphatic aldehyde 6 and N-chlorosuccinimide (NCS) are treated with (S)-proline, a series of well-orchestrated reactions occur19. First, the aldehyde undergoes α-chlorination20, producing a racemic mixture of α-chloroaldehydes 7. Second, an enantioselective proline-catalysed aldol reaction occurs between the dioxanone 8 and the α-chloroaldehyde (R)-7. Importantly, proline also catalyses racemization of the α-chloroaldehydes 7 and, consequently, this second step effects a dynamic kinetic resolution (DKR)19. Thus, this one-pot reaction transforms commodity chemicals 6 and 8 into carbohydrate building blocks 9 in excellent yield, diastereoselectivity and enanantioselectivity. Considering the spatial relationship between the chloromethine and carbonyl functions in 9, these aldol adducts may also serve as building blocks21,22,23,24 for the synthesis of polyhydroxypyrrolidines via a reductive amination–annulation sequence (see grey box, Fig. 2). Such a strategy would allow for the conversion of virtually any acetaldehyde derivative 6 into an iminosugar 10 in two straightforward transformations from commodity chemicals, thus enabling their integration with modern high-throughput screening technologies.
Here we demonstrate that the reductive amination of a wide range of ketochlorohydrins 9 provides a rapid route to pyrrolidine iminosugars8,11,25,26,27,28,29,30,31,32, such as those depicted in Fig. 1. Importantly, this unique two- or three-step process requires no cryogenic, anhydrous or otherwise complicated experimental conditions. The demonstration of this strategy in several short syntheses of biologically active imino-C-nucleoside analogues, and indolizidine and pyrrolizidine iminosugars highlights its adaptability for DOS and the rapid preparation of iminosugar-based screening libraries26.
Reductive amination of α-chlorination-DKR aldol products
The utility of the synthetic strategy outlined in Fig. 2 relies intimately on a diastereoselective reductive amination of aldol adducts 9. Enders has reported27 that the reductive amination of related aldol adducts that lack a chloromethine function were non selective (dr<2:1) using NaB(OAc)3H. Likewise, Madsen found similar selectivities in the reductive amination of the corresponding syn-aldol adduct33. Bearing this in mind, we began by screening solvents and reducing agents, as well as the addition of acetic acid to the reductive amination of ketochlorohydrin 11 (Table 1) (ref. 19). In all cases, an excess of amine was required for complete imine formation and avoidance of competing ketone reduction (entry 1). As indicated in entry 2, the conditions reported by Enders27 delivered the amino alcohols 12a and 12b in good yield (82%), albeit low diastereoselectivity. The relative stereochemistry of 12a was assigned based on analysis of 3JH,H coupling constants and NOESY spectra recorded on the cyclic carbamate derived from the reaction of 12a with carbonyldiimidazole. Use of NaB(CN)H3 resulted in an improved diastereomeric ratio of these products (dr ∼6:1) in both CH2Cl2 and MeCN (entries 3 and 4) and in tetrahydrofuran (THF) the 1,3-syn amino alcohol 12a was produced as the only detectable diastereomer in near quantitative yield (entry 5). As summarized in entries 6 and 7, this optimized protocol proved general and also provided access to the corresponding N-allyl and N-propargyl amines 13a and 14a, in excellent yield and diastereoselectivity.
Synthesis of pyrrolidine iminosugars
While the aminochlorohydrin 12a did not cyclize directly, its high-yielding conversion into the pyrrolidine iminosugar 15 simply required heating in methanol, which also promoted acetonide removal (Fig. 3). Alternatively, this cyclization could be effected by heating 12a in toluene with excess NaHCO3, which provided the orthogonally protected iminosugar 16. Anticipating that the increased reactivity of a benzylchlorohydrin would favour a one-pot reductive amination–annulation process, the readily available aldol adduct 17 (ref. 19) was also treated with NaB(CN)H3 in a mixture of THF/HOAc. Following this optimized procedure, the orthogonally protected iminosugar 18 was produced directly and in excellent yield. Removal of both the acetonide and benzyl-protecting groups by hydrogenolysis in acidic methanol gave the imino-C-nucleoside analogue 4. Considering the aldol adduct 17 is available in one step from phenyl acetaldehyde19, this three-step synthesis of 4, a potent (Ki=170 nM) transition-state analogue inhibitor of nucleoside hydrolase5, represents a significant advance.
Scope of direct iminosugar synthesis
To further evaluate the scope of this direct iminosugar synthesis, we repeated the reactions described in Fig. 3 with several additional alkyl- and aryl-substituted ketochlorohydrins prepared in one step using our (S)-proline-catalysed α-chlorination-DKR aldol reaction19. It is noteworthy that the enantiomeric ketochlorohydrins are also readily prepared using the corresponding (R)-proline-catalysed reaction19. As indicated in Fig. 4, the reductive amination–annulation process is general and delivers a wide range of polyhydroxypyrrolidines 22–43 in good to excellent overall yield. A number of the orthogonally protected iminosugars depicted in Fig. 4 are crystalline and their structures were confirmed by X-ray crystallographic analysis (Supplementary Information). As expected (vide supra), the synthesis of alkyl-substituted iminosugars required an additional cyclization step, whereby the product of reductive amination was heated in MeOH or toluene with NaHCO3. Thus, this convenient process can be tailored for the production of orthogonally protected (22, 24, 26, 28 and 30) or native iminosugars (23, 25, 27, 29 and 31). Conversely, reductive amination of aryl-substituted chlorohydrins provided the corresponding iminosugars 18 and 36–39 directly and in excellent yield. It is notable that both the one- and two-step iminosugar syntheses proved tolerant of various functional groups. For example, electron deficient aryl (36 and 37), electron rich aryl (38) and heteroaryl substituents (39) were readily incorporated. Likewise, alkyl (22–35), branched alkyl (24), silyloxy alkyl (32), allyl (26), propargyl (28), primary alkyl chloride (33) and benzyl (30) groups were all compatible with the reaction sequence. The use of benzyl amine (22–39), allyl amine (40–41) or propargyl amine (42–43) also highlights the utility of this process for DOS and the potential for further elaboration of these iminosugars through metathesis, click, or cross coupling reactions. Finally, the mild reaction conditions and the protecting-group compatibility deserves note, as the 1,3-dioxane function in 34 and 35, silyl protecting group in 32 and 43, and acetonide function (conditions a)) in all substrates remained intact throughout the reaction sequence. Importantly, these readily available iminosugars share many features considered optimal for lead identification34,35,36,37, including MW <350 DA, CLogP <2, multiple chiral centres, heterocyclic rings and H-bond donors/acceptors. In addition, the ease with which the amine function and ring substituent (R1 and R2 in 20) can be differentiated provides unique opportunities for further diversification.
Short syntheses of polyhydroxy pyrrolizidines and indolizidines
Figure 5 highlights the further application of this convenient strategy to the rapid preparation of several structurally complex polyhydroxy indolizidine and pyrrolizidine alkaloids, including analogues of the glycosidase inhibitors hyacinthacine and steviamine. While several strategies could be exploited for the second annulation event, ready access to the N-allyl pyrrolidine 40, alkyl chloride 33 and protected ketones 34 and 35 suggested annulation events involving ring closing metathesis38,39, alkylation24,40,41 or reductive amination17,42. For example, heating the dienylpyrrolidine 40 with the Hoveyda–Grubbs 2nd generation catalyst43 in toluene provided the unsaturated indolizidine 45 in excellent overall yield from 4-pentenal (44). Alternatively, starting with 6-chloropentanal (46) or 5-chloropentanal (48), α-chlorination-DKR aldol reactions19 followed by reductive amination and cyclization provided the chloroalkylpyrrolidine 33 and pyrrolizidine 49, respectively. Conversion of 33 into the corresponding indolizidine 47 (ref. 44) required hydrogenolytic removal of the benzyl-protecting group and brief treatment with base. Completion of the total synthesis of 7a-epi-hyacinthacine A1 (50)45,46 simply involved hydrogenolysis of 49 in acidic media.
The reductive amination strategy was explored in short syntheses of the hyacinthacine and steviamine analogues 2 (ref. 17) and ent-3 (ref. 18). In both cases, the ketone function in the readily available pyrrolidines 34 and 35 was unveiled in concert with hydrogenolytic cleavage of the N-benzyl group, and the resulting iminium species (not shown) was reduced in situ to afford the products depicted as single diastereomers. Importantly, each of the total syntheses depicted in Fig. 5 requires 5 steps or less, originates with inexpensive and readily available chemicals, and is completed in a matter of days, which compares well with the reported syntheses of these and related compounds (see for example, Fig. 1).
In summary, a highly convergent synthesis of iminosugars has been developed that converts a wide range of acetaldehyde derivatives into polyhydroxypyrrolidines in two or three straightforward reactions and does not rely on carbohydrate building blocks. The application of this cost-effective process to the rapid synthesis of indolizidine and pyrrolizidine iminosugars also highlights its utility for the preparation of more structurally complex natural products and their analogues. Importantly, the excellent overall yields, diastereoselectivity and enantioselectivity, coupled with tunability of pharmacophoric features make this process well suited for chemical screening library and DOS campaigns.
Representative example of reductive amination/annulation sequence
Synthesis of aminochlorohydrin 18 and iminocyclitol 4. To a stirred solution of 17 (ref. 19; 130 mg, 0.457 mmol) in THF (4.55 ml) was added BnNH2 (125 μl, 1.15 mmol) and glacial acetic acid (27.0 μl, 0.457 mmol), and the resulting mixture was stirred at 20 °C for 1 h. NaB(CN)H3 (72 mg, 1.15 mmol) was then added and the mixture was stirred for one additional hour. The reaction mixture was then diluted with CH2Cl2 to a concentration of 0.05 M and treated with water. The layers were separated and the organic layer was washed with brine, dried (MgSO4) and concentrated under reduced pressure. Purification of the crude product by flash chromatography (pentane-EtOAc 8:2) afforded pyrrolidine 18 (126 mg, 81% yield) as a crystalline solid. mp=108–111 °C (EtOH); Rf (pentane-EtOAc 6:4) 0.81; [α]D20=+11 (c 0.70 in CHCl3); infrared (neat): ɛ=3444, 2988, 2874, 1454, 1381, 1210, 1048, 853, 753 and 700 cm−1; 1H-nuclear magnetic resonance (1H-NMR; 600 MHz, CDCl3): δ=7.53 (d, J=7.4 Hz, 2H), 7.38 (t, J=7.5 Hz, 2H), 7.31–7.20 (m, 6H), 4.03 (d, J=4.4 Hz, 1H), 3.90 (d, J=12.9 Hz, 1H), 3.74 (s, 1H), 3.74 (dd, J=4.5 Hz, J=9.6 Hz, 1H), 3.47 (d, J=12.8 Hz, 1H), 3.46 (dd, J=10.5 Hz, 1H), 3.25 (dd, J=4.1 Hz, J=10.5 Hz, 1H), 2.89 (ddd, J=4.1 Hz, J=10.5 Hz, 1H), 2.31 (s, 1H), 1.42 (s, 3H) and 1.40 p.p.m. (s, 3H); 13C-NMR (151 MHz, CDCl3): δ=141.3, 139.2, 128.9, 128.5, 128.2, 127.4, 127.4, 127.3, 100.3, 76.9, 76.8, 74.1, 67.2, 59.6, 58.7, 29.2 and 19.8 p.p.m.; HRMS ESI (high-resolution mass spectrometry electrospray ionization) m/z calcd (calculated) for C21H26NO3 [M+H]+ 340.1907, found 340.1886.
Preparation of the imino-C-nucleoside analogue 4
A solution of 18 (20 mg, 0.059 mmol) and pyridinium p-toluenesulfonate (15 mg, 0.059 mmol) in 1:1 H2O/MeOH (4.0 ml) was added to a microwave vial. The vial was sealed in a CEM Discover LabMate microwave reactor and the resulting mixture was heated at 100 °C (as monitored by a vertically focused infrared temperature sensor) for 30 min. The resulting solution was concentrated under reduced pressure and the crude product was used in the next reaction without further purification. A solution of the crude iminocyclitol p-toluenesulfonate salt in MeOH (20 ml) was passed twice through an H-Cube continuous-flow reactor using a 30 mm 10% Pd/C cartridge. Conditions: temperature=35 °C; flow rate=0.8 ml min−1; H2 pressure=40 bar. The resulting mixture was stirred with DOWEX 1X8-100 (HO− form) for a further 30 min and the resin was removed by filtration. Concentration and purification of the crude product by flash chromatography on C18 silica gel (H2O) afforded iminoribitol 4 (10 mg, 83% yield over 2 steps) as a colourless oil. [α]D20=−31 (c 0.48 in MeOH); infrared (neat): ɛ=3306, 2918, 1560, 1494, 1454, 1406, 1347, 1081, 951, 757 and 699 cm−1; 1H-NMR (400 MHz, CD3OD): δ=7.45-7.42 (m, 2H), 7.37-7.32 (m, 2H), 7.27 (ddt, J=1.4 Hz, J=6.4 Hz, J=8.5 Hz, 1H), 4.01 (d, J=7.2 Hz, 1H), 3.97 (dd, J=4.7 Hz, J=6.0 Hz, 1H), 3.86 (dd, J=6.1 Hz, J=7.2 Hz, 1H), 3.74 (d, J=4.5 Hz, 2H) and 3.15 p.p.m. (q, J=4.5 Hz, 1H); 13C-NMR (151 MHz, CD3OD): δ=142.6, 129.5, 128.5, 128.1, 79.2, 73.6, 68.1, 66.8 and 63.2 p.p.m.; HRMS (ESI) m/z calcd for C11H15NO3 [M+H]+ 210.1125, found 210.1111.
Accession codes: The X-ray crystallographic coordinates for structures reported in this study have been deposited at the Cambridge Crystallographic Data Centre (CCDC), under deposition numbers 1038918-1038924. These data can be obtained free of charge from CCDC via www.ccdc.cam.ac.uk/data_request/cif.
How to cite this article: Bergeron-Brlek, M. et al. Direct synthesis of imino-C-nucleoside analogues and other biologically active iminosugars. Nat. Commun. 6:6903 doi: 10.1038/ncomms7903 (2015).
Compain, P. & Martin, O. Iminosugars from Synthesis to Therapeutic Applications Wiley (2007).
Lillelund, V. H., Jensen, H. H., Liang, X. & Bols, M. Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin. Chem. Rev. 102, 515–553 (2002).
Asano, N. Naturally occurring iminosugars and related compounds: structure, distribution, and Biological activity. Curr. Top. Med. Chem. 3, 471–484 (2003).
Asano, N. in Glycoscience eds Fraser-Reid B., Tatsuta K., Thiem J. 1887–1911Springer-Verlag (2008).
Horenstein, B. A., Zabinski, R. F. & Schramm, V. L. A new class of C-nucleosides. 1-(S)-aryl-1,4-dideoxy-1,4-imino-D-ribitols, transition state analogue inhibitors of nucleoside hydrolase. Tetrahedron Lett. 34, 7213–7216 (1993).
Kicska, G. A. et al. Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes. Proc. Natl Acad. Sci. USA 98, 4593–4598 (2001).
Liu, J. S., Shikhman, A. R., Lotz, M. K. & Wong, C.-H. Hexosaminidase inhibitors as new drug candidates for the therapy of osteoarthritis. Chem. Biol. 8, 701–711 (2001).
Liang, P.-H. et al. Novel five-membered iminocyclitol derivatives as selective and potent glycosdidase inhibitors: new structures for antivirals and osteoarthritis. ChemBioChem 7, 165–173 (2006).
Hong, Z., Liu, L., Sugiyama, M., Fu, Y. & Wong, C.-H. Concise synthesis of iminocyclitols via petasis-type aminocyclization. J. Am. Chem. Soc. 131, 8352–8353 (2009).
Compain, P., Chagnault, V. & Martin, O. R. Tactics and strategies for the synthesis of iminosugar C-glycosides: a review. Tetrahedron: Asymm. 20, 672–711 (2009).
Stocker, B. L., Dangerfield, E. M., Win-Mason, A. L., Haslett, G. W. & Timmer, M. S. M. Recent developments in the synthesis of pyrrolidine-containing iminosugars. Eur. J. Org. Chem. 9, 1615–1637 (2010).
Yokoyama, M. & Momotake, A. Synthesis and biological activity of azanucleosides. Synthesis 9, 1541–1554 (1999).
Merino, P., Tejero, T. & Delso, I. Current developments in the synthesis and biological activity of aza-C-nucleosides: immucillins and related compounds. Curr. Med. Chem. 15, 954–967 (2008).
Evans, G. B., Furneaux, R. H., Hausler, H., Larsen, J. S. & Tyler, P. C. Imino-C-nucleoside synthesis: heteroaryl lithium carbanion additions to a carbohydrate cyclic imine and nitrone. J. Org. Chem. 69, 2217–2220 (2004).
Evans, G. B., Furneaux, R. H., Gainsford, G. J., Schramm, V. L. & Tyler, P. C. Synthesis of transition state analogue inhibitors for purine nucleoside phosphorylase and N-riboside hydrolases. Tetrahedron 56, 3053–3062 (2000).
Evans, G. B. et al. Addition of lithiated 9-deazapurine derivatives to a carbohydrate cyclic imine: convergent synthesis of the aza-C-nucleoside immucillins. J. Org. Chem. 66, 5723–5730 (2001).
Izquierdo, I., Plaza, M. T., Tamayo, J. A., Rodríguez, M. & Martos, A. Polyhydroxylated pyrrolizidines. Part 8: enantiospecific synthesis of looking-glass analogues of hyacinthacine A5 from DADP. Tetrahedron 62, 6006–6011 (2006).
Ansari, A. A. & Vankar, Y. D. Synthesis of dihydroxymethyl dihydroxypyrrolidines and steviamine analogues from C-2 formyl glycals. J. Org. Chem. 78, 9383–9395 (2013).
Bergeron-Brlek, M., Teoh, T. & Britton, R. A tandem organocatalytic α-chlorination-aldol reaction that proceeds with dynamic kinetic resolution: a powerful tool for carbohydrate synthesis. Org. Lett. 15, 3554–3557 (2013).
Halland, N., Braunton, A., Bachmann, S., Marigo, M. & Jørgensen, K. A. Direct organocatalytic asymmetric α-chlorination of aldehydes. J. Am. Chem. Soc. 126, 4790–4791 (2004).
Britton, R. & Kang, B. α-Haloaldehydes: versatile building blocks for natural product synthesis. Nat. Prod. Rep. 30, 227–236 (2013).
Draper, J. & Britton, R. A concise and stereoselective synthesis of hydroxypyrrolidines: rapid synthesis of (+)-preussin. Org. Lett. 12, 4034–4037 (2010).
Dhand, V., Draper, J. A., Moore, J. & Britton, R. A short, organocatalytic formal synthesis of (–)-swainsonine and related alkaloids. Org. Lett. 15, 1914–1917 (2013).
Dhand, V., Chang, S. & Britton, R. Total synthesis of the cytotoxic anhydrophytosphingosine pachastrissamine (jaspine B). J. Org. Chem. 78, 8208–8213 (2013).
Crabtree, E. V. et al. Synthesis of the enantiomers of XYLNAc and LYXNAc: comparison of β-N-atecylhexosaminidase inhibition by the 8 stereoisomers of 2-N-acetylamino-1,2,4-trideoxy-1,4-iminopentinols. Org. Biomol. Chem. 12, 3932–3943 (2014).
Saotome, C., Wong, C.-H. & Kanie, O. Combinatorial library of five-membered iminocyclitol and the inhibitory activities against glycol-enzymes. Chem. Biol. 8, 1061–1070 (2001).
Enders, D., Paleček, J. & Grondal, C. A direct organocatalytic entry to sphingoids: asymmetric synthesis of D-arabino- and L-ribo-phyto sphingosine. Chem. Commun. 6, 655–657 (2006).
Brandi, A., Cardona, F., Cicchi, S., Cordero, F. M. & Goti, A. Stereocontrolled cyclic nitrone cycloaddition strategy for the synthesis of pyrrolizidine and indolizidine alkaloids. Chem. Eur. J. 15, 7808–7821 (2009).
Medjahdi, M., González-Gómez, J., Foubelo, F. & Yus, M. Stereoselective synthesis of azetidines and pyrrolidines from N-tert-butylsulfonyl(2-aminoalkyl)oxiranes. J. Org. Chem. 74, 7859–7865 (2009).
Davis, F. A., Yang, B. & Deng, J. Asymmetric synthesis of cis-5-tert-butylproline with metal carbenoid NH insertion. J. Org. Chem. 68, 5147–5152 (2003).
Dangerfield, E. M., Timmer, M. S. M. & Stocker, B. L. Total synthesis without protecting groups: pyrrolidines and cyclic carbamates. Org. Lett. 11, 535–538 (2009).
Dekeukeleire, S., D’hooghe, M., Törnroos, K. W. & De Kimpe, N. Stereoselective synthesis of chiral 4-(1-chloroalkyl)-β-lactams starting from amino acids and their transformation into functionalized chiral azetidines and pyrrolidines. J. Org. Chem. 75, 5934–5940 (2010).
Lauritsen, A. & Madsen, R. Synthesis of naturally occurring iminosugars from d-fructose by the use of a zinc-mediated fragmentation reaction. Org. Biomol. Chem. 4, 2898–2905 (2005).
Lovering, F., Bikker, J. & Humblet, C. Escapade from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem. 52, 6752–6756 (2009).
Walters, W. P. Going further than Lipinski’s rule in drug design. Exper. Opin. Drug. Discov. 7, 99–107 (2012).
Feher, M. & Schmidt, J. M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci. 43, 218–227 (2003).
Pascolutti, M. & Quinn, R. J. Natural products as lead structures: chemical transformations to create lead-like libraries. Drug Discov. Today 19, 215–221 (2014).
Verhelst, S. H. L. et al. A Short route toward chiral, polyhydroxylated indolizidines and quinolizidines. J. Org. Chem. 68, 9598–9603 (2003).
Jiangseubchatveera, N. et al. Concise synthesis of (–)-steviamine and analogues and their glycosidase inhibitory activities. Org. Biomol. Chem. 11, 3826–3833 (2013).
Parmeggiani, C., Cardona, F., Giusti, L., Reissig, H.-U. & Goti, A. Stereocomplementary routes to hydroxylated nitrogen heterocycles: total syntheses of casuarine, australine, and 7-epi-australine. Chem. Eur. J. 19, 10595–10604 (2013).
Wardrop, D. J. & Bowen, E. G. Nitrenium ion-mediated alkene bis-cyclofunctionalization: total synthesis of (–)-swainsonine. Org. Lett. 13, 2376–2379 (2011).
Randl, S. & Blechert, S. Concise enantioselective synthesis of 3,5-dialkyl-substituted indolizidine alkaloids via sequential cross-metathesis-double-reductive cyclization. J. Org. Chem. 68, 8879–8882 (2003).
Garber, S. B., Kingsbury, J. S., Gray, B. L. & Hoveyda, A. H. Efficient and recyclable monomeric and dendritic Ru-based metathesis catalysts. J. Am. Chem. Soc. 122, 8168–8179 (2000).
Gómez, L. et al. Chemoenzymatic synthesis, structural study and biological activity of novel indolizidine and quinolizidine iminocyclitols. Org. Biomol. Chem. 10, 6309–6321 (2012).
Izquierdo, I., Plaza, M. T., Tamayo, J. A., Franco, F. & Sánchez-Cantalejo, F. Total synthesis of natural (+)-hyacinthacine A6 and non-natural (+)-7a-epi-hyacinthecine A1 and (+)-5,7a-diepi-hyacinthacine A6 . Tetrahedron 66, 3788–3794 (2010).
Brock, E. A., Davies, S. G., Lee, J. A., Roberts, P. M. & Thomson, J. E. Asymmetric synthesis of polyhydroxylated pyrrolizidines via transannular iodoamination with concomitant N-debenzylation. Org. Lett. 13, 1594–1597 (2011).
This work was supported by an NSERC Discovery Grant to R.B., a Michael Smith Foundation for Health Research Career Investigator Award to R.B., a Multi-Investigator Research Initiative grant (funded by Brain Canada, Genome BC, Michael Smith Foundation for Health Research; and the Pacific Alzheimer Research Foundation), an NSERC PGSD for M.B.-B.; and a NSERC USRA for M.M.
The authors declare no competing financial interests.
Supplementary Figures 1-59, Supplementary Tables 1-8, Supplementary Methods and Supplementary References (PDF 10066 kb)
X Ray Structure (compound 18) (CIF 361 kb)
X Ray Structure (compound 23-OAc) (CIF 207 kb)
X Ray Structure (compound 26) (CIF 672 kb)
X Ray Structure (compound 28) (CIF 333 kb)
X Ray Structure (compound 30) (CIF 518 kb)
X Ray Structure (compound 40) (CIF 300 kb)
X Ray Structure (compound ent-3) (CIF 622 kb)
About this article
Cite this article
Bergeron-Brlek, M., Meanwell, M. & Britton, R. Direct synthesis of imino-C-nucleoside analogues and other biologically active iminosugars. Nat Commun 6, 6903 (2015). https://doi.org/10.1038/ncomms7903
Communications Chemistry (2021)